Crossmark

Predictive potential of macrophage migration inhibitory factor (MIF) in patients with heart failure with preserved ejection fraction (HFpEF)

Published Online: 2018-05-04

Published Print: 2018-12

Authors

Luedike, Peter

Alatzides, Georgios

Papathanasiou, Maria

Heisler, Martin

Pohl, Julia

Lehmann, Nils

Rassaf, Tienush
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct03232671 at ClinicalTrials.gov

Documents that mention this clinical trial

Predictive potential of macrophage migration inhibitory factor (MIF) in patients with heart failure with preserved ejection fraction (HFpEF)
https://doi.org/10.1186/s40001-018-0321-1
Funding

Funding for this research was provided by:

German Cardiac Society DGK (Otto-Hess Stipendium)

Deutsche Forschungsgemeinschaft (LU2139/2-1)

Deutsche Forschungsgemeinschaft (Ra969/7-2)
License Information

Text and Data Mining valid from 2018-05-04

Version of Record valid from 2018-05-04
More Information

Article History

Received: 13 April 2018

Accepted: 28 April 2018

First Online: 4 May 2018

Document is current